FDA approves the first postpartum depression pill

The FDA approved the first pill for postpartum depression on Friday. The drug is called zuranolone, and unlike other antidepressants, it's specifically designated for postpartum depression, a condition that affects around 1 in 7 new mothers. The big picture: Zuranolone is taken daily for two weeks. Clinical trials showed that the drug could ease depression in as little as three days. Plus, young workers are redefining the American dream. And, Spanglish is making a comeback. Guests: Axios' Felix Salmon, Arielle Dreher and Marina Franco. Credits: Axios Today is produced by Erica Pandey, Alexandra Botti, Fonda Mwangi, Robin Linn and Alex Sugiura. Music is composed by Evan Viola. You can reach us at podcasts@axios.com. You can text questions, comments and story ideas to Niala as a text or voice memo to 202-918-4893.

Om Podcasten

Axios podcast host Niala Boodhoo digs deep with leaders you know — or need to know — in business, politics and culture. Every week, all in under 20 minutes. About Axios: Axios is a digital media company launched in 2017. Axios helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app.  About Niala Boodhoo: Niala Boodhoo is the host of 1 big thing and previously hosted Axios Today She was the founding Host and Executive Producer of the award-winning news program The 21st. An alum of Reuters, The Miami Herald and WBEZ/Chicago, Niala was a 2019-2020 Knight-Wallace fellow.